CEACAM5 and lung carcinoma: Serum tumour markers are widely used in the diagnosis and prognostic monitoring of lung cancer, and carcinoembryonic antigen (CEA) is one of the most sensitive markers (Moertel et al., 1993; Plebani et al., 1995; Molina et al., 2009).